Search

everythinglearnresearchcommunity

for

Search:↓

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Soy isoflavones can protect lung tissue from radiation damage.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Taking five small dutasteride capsules is the same as taking one larger capsule.

Many research paper titles in dermatology journals lack scientific precision.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Untreated androgenetic alopecia leads to progressive hair loss in men.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Using the eye pressure medication latanoprost can cause excessive hair growth and darker eyelashes on the treated eye.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Certain drugs that block specific enzymes can help treat prostate diseases.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.